Healthcare & Life Sciences
Glycostem Therapeutics B.V
Netherlandswww.glycostem.com
Glycostem Therapeutics B.V is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series A, 2 tracked investors.
activeseries-a
series-a
Stage
2
Investors
About Glycostem Therapeutics B.V
Glycostem Therapeutics B.V is a startup based in the Netherlands. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Glycostem Therapeutics develops allogeneic off-the-shelf Natural Killer (NK) cell therapies derived from umbilical cord blood stem cells to treat various cancers including acute myeloid leukemia and multiple myeloma.
Explore Glycostem Therapeutics B.V's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.